bjoern.nashan
近期热点
资料介绍
个人简历
主要学习、工作、出国经历1987 – 2000: 历任外科学讲师、副教授,汉诺威医学院2000 – 2004: 外科学教授, 汉诺威医学院2004 – 2007: 教授,加拿大Dalhousie大学2007 – 2016: 普通外科、血管外科、器官移植外科主任,汉堡大学研究领域
肝胆胰外科及肝移植外科临床及基础研究: 1. 移植排斥免疫反应信号通路 2. 移植术后病人个体化免疫抑制策略 3. 肝移植和肝胆胰外科的临床研究"目前正在承担的科研项目(仅限于主要负责人)项目名称、来源、经费指标卡号 总经费(万元) 起止日期ACTICCA Trial:Adjuvant chemotherapy with gemcitabine and cisplatine compareid to observation after curative intent resection of cholangiocarcinoma – A randomized近期论文
1. Avoid All-Touch by Hybrid ALPPS to Achieve Oncological Efficacy. Annals of surgery. 10.1097/SLA.00000000000008452. Kidney transplantation in small children: Donor selection and technical consideration. Transplantation. 2002; 73: 409-16.3. Preoperative volume calculation of the hepatic venous draining areas with multi-detector row CT in adult living donor liver transplantation: impact on surgical procedure. Eur Radiol 20064.Comparing Surgical Complications of Donors and Recipients in Retroperitoneoscopic versus Mini-Incision Donor Nephrectomy: A Single-Center Exp发表论文名称(近5年)Review of cytomegalovirus infection findings with mammalian target of rapamycin inhibitor-based immunosuppressive therapy in de novo renal transplant. Transplantation. 2012 Jun 15;93(11):1075-85.Nashan B, Gaston R, Emery V, Säemann MD, Mueller NJ, Couzi L, Dantal J, Shihab F, Mulgaonkar S, Seun Kim Y, Brennan DC。Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Rev Med Virol. 2013 Mar;23(2):97-125.Brennan DC, Aguado JM, Potena L, Jardine AG, Legendre C, Säemann MD, Mueller NJ, Merville P, Emery V, Nashan BLack of association between CTLA-4 and PDCD1 polymorphisms and acute rejection in German liver transplant recipients. Hum Immunol. 2013 Apr 27.Thude H, Schipler AD, Treszl A, Peine S, Koch M, Sterneck M, Nashan BFour-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with. rituximab, splenectomy, and bortezomib. Transpl Int. 2013 Apr 26.Koch M, Gräser C, Lehnhardt A, Pollok JM, Kröger N, Verboom M, Thaiss F, Eiermann T, Nashan BInduction therapy and mTOR inhibition: minimizing calcineurin inhibitor exposure in de novo renal transplant patients. Clin Transplant. 2013 Jul;27 Suppl 25:16-29.Nashan BThe role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy. CLIN TRANSPLANT, 28(6), 635-48. 10.1111/ctr.12357。Klintmalm GB, Saab S, Hong JC, Nashan BLack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients. HUM IMMUNOL, 75(11), 1123-7.Thude H, Kramer K, Koch M, Peine S, Sterneck M, Nashan BmTOR inhibitors and their role in modern concepts of immunosuppression. WORLD J SURG, 38(12), 3199-201.Nashan BAvoid All-Touch by Hybrid ALPPS to Achieve Oncological Efficacy. Annals of surgery.Li J, Kantas A, Ittrich H, Koops A, Achilles E., Fischer L, Nashan BEvaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. TRIALS, 16(1), 118.Nashan B, Schemmer P, Braun F, Dworak M, Wimmer P, Schlitt H 相关热点
最新收录
- 水咲优美(水咲優美) 06-25
- 三月光(三月ひかる) 06-21
- 澪川遥(澪川はるか) 06-21
- 冈本莉里 岡本莉里 (おか 06-21
- 宗像丽奈(宗像れな) 06-21
- 温碧霞 06-21
- 舒淇 06-21
- 叶玉卿 06-21
- 叶子楣 06-21
- 杨思敏 06-21